2008 Barcelona - European Society of Human Genetics

Keyword Index 0
haemoglobinopathies: C09.3, P08.76
Haemophila: P05.062
Haemophilia A: P05.063
haemophilia: P06.123
Hairpin structure: P08.13
Hajdu-Cheney syndrome: P01.134
HAMP: P06.127
Hand Osteoarthritis: P06.124
Hanhart syndrome: P01.135
haplogroup: P07.110
haploinsufficiency: P04.155
haplotype analysis: P06.152
Haplotype and simulation analyses: P06.228
haplotype: P01.007, P01.022, P03.28,
P04.086, P05.019, P06.042, P06.243
haplotypes: P06.058
haptoglobin: P06.214
Hb F Malta I: P01.020
Hb F Sardegna: P01.020
Hb Lepore: P01.019, P01.022
Hb S: P07.016
Hb Torino: P01.021
HbE/βthalassemia: P01.014
HbF inducers: P10.02
HBOC families: P04.031
HBOC: EPL3.3
HCM: P05.064, P05.065, P05.092, P07.065
HD: EP08.1, EP10.16, EP13.4, P09.37
HDL: P06.148
HDL2: P09.37
HDR syndrome: P02.068
health communication: EW1.1
health professionals: P09.09
healthcare professionals: EP14.05
healthcare system: P09.50
Hearing impairment: C03.2, P06.125
Hearing loss: C03.2, P01.128, P01.279,
P05.055, P05.067, P05.068, P05.069,
P05.072, P05.073, P05.074
hearing: C12.4
hearing-loss: P06.232
Heart defect: P01.174, P02.076
heart defects: P01.136
heart failure: P06.043
heart: P05.033, P08.36
height: C13.1, P06.126, P06.238, P07.060
HEK 293: P04.197
HELLP syndrome: P06.308
Hematologic malignancies: P04.076
hematopeiotic cell: P04.152
hematopoietic stem cells: P10.13
Heme oxigenase 2: P06.031
heme-oxigenase 1: P06.256
Hemochromatosis type IV: P05.076
hemochromatosis: P05.075, P06.127
Hemoglobin: P01.004
Hemoglobinopathy: P01.019, P01.022
hemokinin-1: P05.140
hemophilia A: P05.077, P05.078
Hemophilia B: P05.079
hemophilia: P01.291
Hemostasis: P06.009
Hennekam syndrome: P01.171
hepatic fibrosis: P06.113
Hepatitis C: P02.202
hepatoblastoma: P01.292, P04.153
Hepatocellular carcinoma: P04.206, P10.14
hepcidin: P06.127
HER2/neu and EGFR: P04.171, P04.172
Her-2/neu: P04.162
hereditary angioedema: P05.017
Hereditary breast and ovarian cancer:
EP09.2
Hereditary cystatin C amyloid angiopathy:
C03.5
hereditary deafness: EP14.07
hereditary disorders SCA2, FAP: EP08.7
Hereditary Epidermolysis Bullosa: P05.080
Hereditary hearing loss: P05.081
hereditary hemochromatosis: P07.066,
P07.067
hereditary hemorrhagic telangiectasia:
P01.293
Hereditary Non-Polyposis Colorectal Cancer:
EPL3.1, EPL3.4
Hereditary Proteinuria Syndrome: P05.082
Hereditary spastic paraparesis: P05.083
Hereditary spastic paraplegia: P05.186,
P06.128
Hereditary spastic paraplegias (HSP):
P05.185
hetero-oligomers: P05.138
heteroploidy frequency: P02.224
heteroploidy: P02.229
Heterotopia: P01.239
heterotopic ossification: P05.084
Heterozygosity: P06.178
heterozygous familial hypercholesterolemia:
P06.161
heterozygous: P01.008, P01.241
Hex-A: P01.070
HEXB: P01.068
HFE C282Y: P04.111
HFE gene: P04.049, P07.066
HFE: P06.096
HGPPS: P01.356
HHCS: P05.085
HHT: P01.293, P05.086
HHV-6: P02.011
HIBM: P05.087
-hidroxilase deficiencyα17: P05.030
HIF1A: P06.129
high resolution melting analysis: P08.37
high resolution melting ethylation analysis:
P08.38
high resolution melting point analysis:
P06.221
High resolution melting: P09.70
high-schools: P09.36
high-throughput mutation screening: P06.221
High-throughput-sequencing: C05.1
Histopathological examination of the placenta:
P01.327
history: P09.38
HLA: P06.202, P06.294, P07.128, P07.135,
P10.13
HLA-B*51 alelle: P08.06
HNF1a: P05.131
HNPCC: EPL3.4, P04.016, P04.017,
P04.018, P04.022, P04.023, P04.024
HNPP: P01.238
HNRPU gene: P02.090
holoprosencephaly: P01.294
Holt-Oram: P01.136
home sampling: P10.21
Homeobox Gene: P10.24
homocysteine: P06.143
homocystinuria: P01.050, P05.134
homologues recombination: P10.28
Homozygosity mapping: P05.010, P05.144
homozygosity: P07.068
homozygous robertsonian translocations:
P03.44
hormone resistance: P04.186
hospital-based case-control study: P01.267
host-karyome-microbiome interactions: PL1.1
Hotspot: C13.2, P04.005
HOXD13: C11.1
HPFH: P01.011, P01.015
HPRT1: P01.059
HPS: P04.006
HRAS: P01.189
HR-CGH: P02.007
HRM: P04.069, P05.031, P05.109, P07.069,
P08.39
HR-MCA: P08.40
HSCR: P05.088, P06.130
HSP: P05.186, P05.212, P06.131
HSP90: P06.246
hTERC: P04.096
hTERT, COX2: P04.198
hTERT: P04.096
Hu11cells: P10.15
human development: P08.41
Human diversity: P07.072
human genetics: P07.070, P08.81
human genome: P08.58
Human Leukocyte Antigen Typing: P08.42
human mesenchymal stem cells: P02.151
human metaphase chromosomes: P02.138
human pedigree: P06.132
human placentas: P02.049
human-canine testing model: P06.322
Hunter syndrome: P10.16
Huntington Disease: EP08.1, EP08.2,
P01.296
Huntington disease-like: P01.295
Huntington: EP12.2, P01.295
Huntington’s Disease: EP13.5, EP13.6,
EP14.13, P05.089
Huntington’s: EP13.4
hydrops fetalis: P01.327
hydrops: P01.352
hydroxymethylbilane synthase: P05.161
hydroxyurea: P10.05
hygroma colli: P03.31
Hyperferritinemia: P01.051
hyperinsulinism: P01.297
hyperisulinemia: P01.313
hypermethylation: P04.167
hyperparathyroidism: P06.133
hyperphosphatasia: P01.298